Staff editor

Bayer bets on biotics: new Darmstadt lab to fast-track microbiome-based health solutions

The next wave of gut health products won’t just claim to be natural — they’ll be microbiome-powered and science-certified.

Dietary fiber intake shapes gut microbiota activity and mucin degradation: insights from a human dietary intervention study

Mahesh Desai, group leader of the Eco-Immunology and Microbiome team at the Luxembourg Institute of Health and adjunct associate professor at the University of Southern Denmark, discusses about his research…

Danone opens OneBiome Lab at Paris-Saclay: where the microbiome meets AI

The race toward evidence-based microbiome nutrition has just found its new headquarters.

ROELMI BIOTECH: a new production hub for precision biofermentation in Italy

The company is now taking a decisive step from laboratory-scale research to industrial-scale biofermentation.

The gut microbiota in veterinary medicine: new perspectives between research and nutrition

Professor Alessandro Gramenzi discusses the current knowledge of the gut microbiota in companion animals and the opportunities to modulate it through nutritional interventions.

Synbiotics and autism: a novel microbiome-based strategy to improve gut and behavioral health in children with autism spectrum disorder 

A study demonstrates that synbiotic supplementation, alone or combined with GDH, is a safe and effective adjunct therapy for autistic children with DGBI.

Novonesis and Novo Nordisk Join Forces to Harness the Gut Microbiome for Metabolic Health

The combination of biological innovation and pharmaceutical muscle could create a unique pathway for translating microbiome discoveries into accessible, science-backed solutions for everyday health.

The microbiome and athletic performance: scientific insights and investment landscape

The gut microbiome has emerged not just as a passive bystander in sports, but as an active modulator of athletic energy, recovery, and resilience.

Engineering the gut: Endure Biotherapeutics secures NIH funding for groundbreaking FAP therapy

New funding boosts development of microbiome-based therapies for hereditary cancer risk, opening paths to alternatives beyond surgery.

A $2.5 billion catalyst: how the Gates Foundation is redefining women’s health innovation—with the microbiome in the spotlight

The Bill & Melinda Gates Foundation accelerates research and innovation targeting the most neglected areas of female health.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top